Degradation of drugs in water with advanced oxidation processes and ozone

Journal of Environmental Management

Volumn 137, Issue , 2014, Pages 197-203

  Quero Pastor, Maria ^a   Valenzuela, Alvaro ^b   Quiroga, Jose M ^a   Acevedo, Asuncion ^a  

^a UNIVERSITY OF CÁDIZ   (Spain)

^b Polígono Industrial El Palmar   (Spain)

Author keywords

AOP; Drugs; Mineralization; Ozone; Toxicity

Indexed keywords

DRUG PRODUCTS; MINERALOGY; TOXICITY;

ADVANCED OXIDATION PROCESSES; AOP; ATMOSPHERIC AIR; CLOFIBRIC ACID; CONDITION; DRUG; FEED GAS; MINERALISATION; OZONE TREATMENT; PRESSURE SWING ADSORPTION TECHNOLOGIES;

OZONE;

CLOFIBRIC ACID; GROUND WATER; HYDROGEN PEROXIDE; IBUPROFEN; OZONE; SURFACE WATER; WATER; OXIDIZING AGENT; OXYGEN; WATER POLLUTANT;

CONCENTRATION (COMPOSITION); DEGRADATION; DRUG; MINERALIZATION; OXIDATION; OZONE; WATER POLLUTION; WATER QUALITY;

ADSORPTION; AMBIENT AIR; AQUATIC ENVIRONMENT; AQUEOUS SOLUTION; ARTICLE; CONDUCTANCE; DRUG DEGRADATION; ECOTOXICOLOGY; ENVIRONMENTAL PROTECTION; MINERALIZATION; OXIDATION; PHYTOTOXICITY; WATER CONTAMINATION; AIR; CHEMISTRY; OXIDATION REDUCTION REACTION; PROCEDURES; WATER MANAGEMENT; WATER POLLUTANT;

ADSORPTION; AIR; CLOFIBRIC ACID; HYDROGEN PEROXIDE; IBUPROFEN; OXIDANTS; OXIDATION-REDUCTION; OXYGEN; OZONE; WATER POLLUTANTS, CHEMICAL; WATER PURIFICATION;

EID: 84897047339     PISSN: 03014797     EISSN: 10958630     Source Type: Journal    
DOI: 10.1016/j.jenvman.2014.02.011     Document Type: Article

References (43)

1. 2/UV treatment of clofibric acid in water: a kinetic investigation. J.Hazard. Mater. 2003, 103(3):233-246.
2. Ashbolt N.J. Risk analysis of drinking water microbial contamination versus disinfection by-products (DBPs). Toxicoogy 2004, 198(1-3):255-262.
3. Bes-Pi A., Iborra-Clar A., Mendoza-Roca J.A., Iborra-Clar M.I., Alcaina-Miranda M.I. Nanofiltration of biologically treated textile effluents using ozone as a pre-treatment. Desalination 2004, 167:387-392.
4. Cleuvers M. Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicol. Lett. 2003, 142(3):185-194.
5. Cleuvers M. Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid. Ecotoxicol. Environ. Saf. 2004, 59(3):309-315.
6. Coelho A., Sans C., Esplugas S., Dezotti M. Ozonation of NSAID: biodegradability and toxicity study. Ozone: Sci. Eng. 2010, 32:91-98.
7. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ. Health Perspect. 1999, 107(6):907-938.
8. Drábková M., Admiraal W., Blahoslav M. Combined exposure to hydrogen peroxide and lights selective effects on cyanobacteria, Green algae, and diatoms. Environ. Sci. Technol. 2007, 41:309-314.
9. 2 on cyanobacterial photosynthesis. Photosynthetica 2007, 45(3):363-369.
10. Garrido J.A., Brillas E., Cabot P.L., Centellas F., Arias C., Rodríguez R.M. Mineralization of drugs in aqueous medium by advanced oxidation processes. Port. Electrochim. Acta 2007, 25(1):19.
11. Garrido-Perez M.C., Perales-Vargas Machuca J.A., Nebot-Sanz E., Sales-Márquez D. Effect of the test media and toxicity of LAS on the growth of Isochrysis galbana. Ecotoxicology 2008, 17(8):738-746.
12. Heberer T., Stan H.J. Determination of trace levels of dichlorprop, mecoprop, clofibric acid, and Naphthylacetic acid in Soil by Gas Chromatography/Mass spectrometry with selected-ion monitoring. J.AOAC Int. 1996, 79(6):1428-1433.
13. Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data 2002, 131(1-2):5-17.
14. Hignite C., Azarnoff D.L. Drugs and drug metabolites as environmental contaminants: chlorophenoxyisobutyrate and salicylic acid in sewage water effluent. Life Sci. 1977, 20(2):337-342.
15. Hoigne J. Chemistry of Aqueous Ozone and Transformation of Pollutants by Ozonation and Advanced Oxidation Processes. The Handbook of Environmental Chemistry 1998, vol. 5:83-142.
16. Hua W., Bennett E.R., Letcher R.J. Ozone treatment and the depletion of detectable pharmaceuticalsandantrazine herbicide in drinking water sourced from the upper Detroit River, Ontario, Canada. Water Res. 2006, 40(12):2259-2266.
17. Huber M., Canonica S., Park G.-Y., Von Gunten U. Oxidation of pharmaceuticals during ozonation and advanced oxidation processes. Environ. Sci. Technol. 2003, 37(5):1016-1024.
18. Huber M., Gobel A., Joss A., Hermann N., Loffler D., Mcardell C., Ried A., Siegrist H., Ternes T.A., Von Gunten U. Oxidation of pharmaceuticals during ozonation of municipal wastewater effluents: a pilot study. Environ. Sci. Technol. 2005, 39(11):4290-4299.
19. 2 treatment. Wat. Sci. Technol. 2002, 46(11-12):127-132.
20. Ikehata K., Naghashkar N.J., El-Din M.G. Degradation of aqueous pharmaceuticals by ozonation and advanced oxidation processes: a review. Ozone: Sci. Eng. 2006, 28:353-414.
21. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., Buxton H.T. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 2002, 36(6):1202-1211.
22. Kümmerer K. Pharmaceuticals in the Environment. Annu. Rev. Environ. Resour. 2010, 35:57-75.
23. Lopez-Galindo C., Garrido-Perez M.C., Casanueva J.F., Nebot E. Degradation models and ecotoxicity in marine waters of two antifouling compounds:Sodium hypochlorite and an alkylamine surfactant. Sci. Total Environ. 2010, 408(8):1779-1785.
24. Mohle E., Kempter C., Kern A., Metzger J.W. Examination of the degradation of drugs in municipal sewage plants using liquid chromatography-electrospray mass spectrometry. Acta Hydrochim. Hydrobiol. 1999, 27(6):430-436.
25. Prieto-Rodríguez L., Oller I., Klamerth N., Agüera A., Rodríguez E.M., Malato S. Application of solar AOPs and ozonation for elimination of micropollutants in municipal wastewater treatment plant effluents. Water Res. 2012, 47(4):1521-1528.
26. Quero-Pastor M.J., Garrido-Perez M.C., Acevedo A., Quiroga J.M. Ozonation of ibuprofen: a degradation and toxicity study. Sci. Total Environ. 2014, 466-467:957-964.
27. Rivas F.J., Beltran F.J., Encinas A. Removal of emergent contaminants: integration of ozone and photocatalysis. J.Environ. Manag. 2003, 100(15):10-15.
28. Rodríguez-Vidal F.J. Procesos de potabilización del agua e influencia del tratamiento de ozonización 2003, 13-33. Ediciones Diaz De Santos, SA.
29. Rosal R., Gonzalo M.S., Boltes K., Letón P., Vaquero J.J., García-Calvo E. Identification of intermediates and assessment of ecotoxicity in the oxidation products generated during the ozonation of clofibric acid. J.Hazard. Mater. 2009, 172(2-3):1061-1068.
30. Russell A.D. Similarities and differences in the responses of microorganisms to biocides. J.Antimicrob. Chemother. 2003, 52:750-763.
31. Sires I., Centellas F., Garrido J.A., Rodríguez R.M., Arias C., Cabot P.-L., Brillas E. Mineralization of clofibric acid by electrochemical advanced oxidation processes using a boron-doped diamond anode and Fe2+ and UVA light as catalysts. Appl. Catal. B: Environ. 2007, 72(3-4):373-381.
32. Ternes T.A., Stumpf M., Schuppert B., Haberer K. Simultaneous determination of antiseptics and acidic drugs in sewage and river water. Vom Wasser 1998, 90:295-309.
33. Ternes T. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 1998, 32(11):3245-3260.
34. Ternes T.A., Bonerz M., Schmidt T. Determination of neutral pharmaceuticals in wastewater and rivers by liquid chromatography_/electrospray tandem mass spectrometry. J.Chromatogr. 2001, A 938:175-185.
35. Ternes T.A., Meisenheimer M., McDowell D., Sacher F., Brauch H.-J., Haist-Gulde B., Preuss G., Wilme U., Zulei-Seibert N. Removal of pharmaceuticals during drinking water treatment. Environ. Sci. Technol. 2002, 36(17):3855-3863.
36. Ternes T.A., Stuber J., Herrmann N., McDowell D., Ried A., Kampmann M., Teiser B. Ozonation: a tool for removal of pharmaceuticals, contrast media, and musk fragrances from wastewater. Water Res. 2003, 37(8):1976-1982.
37. Tixier C., Singer H.P., Oellers S., Müller S.R. Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environ. Sci. Technol. 2003, 37(6):1061-1068.
38. Von Gunten U. Ozonation of drinking water: part I. Oxidation kinetics and product formation. Water Res. 2003, 37:1443-1467.
39. Von Sonntag C., Mark G., Mertens R., Schuchmann M.N., Schuchmann P. UV-radiation and/or oxi-dants in water pollution control. Aqua AQUAAA 1993, 42(4).
40. Westerhoff P., Yoon Y., Snyder S., Wert E. Fate of endocrinedisruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. Environ. Sci. Technol. 2005, 39:6649.
41. Yalfani M.S., Contreras S., Llorca J., Medina F. Enhanced Cu activity in catalytic ozonation of clofibric acid by incorporation into ammonium dawsonite. Appl. Catal. B: Environ. 2011, 107(1-2):9-17.
42. Zwiener C., Frimmel F.H. Oxidative treatment of pharmaceuticals in water. Water Res. 2000, 34(6):1881-1885.
43. Zwiener C., Seeger S., Glauner T., Frimmel F.H. Metabolites from the biodegradation of pharmaceutical residues of ibuprofen in biofilm reactors and batch experiments. Anal. Bioanal. Chem. 2002, 372(4):569-575.